Effects of CD34 + cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation.
Takashi OyamaShin-Ichiro FujiwaraRyutaro TominagaDaizo YokoyamaAtsuto NoguchiShuka FurukiShunsuke KoyamaRui MurahashiHirotomo NakashimaKazuki HyodoTakashi IkedaShin-Ichiro KawaguchiYumiko TodaTakashi NagayamaKento UminoDaisuke MinakataKaoru MoritaMasahiro AshizawaChihiro YamamotoKaoru HatanoKazuya SatoIkuko OtsukiKen OhmineYoshinobu KandaPublished in: Clinical transplantation (2024)
cell dose in addition to NCC was useful for predicting hematopoietic recovery, but seemed to have little influence on the long-term outcome in BMT.